about
miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-cateninHigh-density lipoprotein (HDL) metabolism and bone mass.Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.Monoclonal antibodies for treating osteoporosis.Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.New Insights Into the Local and Systemic Functions of Sclerostin: Regulation of Quiescent Bone Lining Cells and Beige Adipogenesis in Peripheral Fat Depots.[Antibodies as treatment option in older adults].Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism.Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy.New agents in the Treatment of Myeloma Bone Disease.Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis.Treatment with anti-Sclerostin antibody to stimulate mandibular bone formation.Bone Turnover Status: Classification Model and Clinical Implications.The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis.FasL Modulates Expression of in Osteoblasts
P2860
Q36270013-BA820080-9DB5-4495-96CA-901D39A9867BQ38743436-F0F5392C-4D3F-4796-AE60-F7BC134432C2Q47141750-83E3F9E1-3E4D-476C-9240-AC0C6DD89C7DQ47638169-89BE2927-25CC-47E3-8213-3BE57F3B50B1Q47909734-7F675A2D-E858-4BBA-B29F-6EB487F54F26Q47926985-8A428029-EA3A-4E51-9962-421ABE530249Q48372695-82F2D70C-7FE8-497D-82B4-5279394C4716Q49560373-EE4056E9-3885-4062-81BC-E36140F4FA84Q50088169-6109CCB8-68B6-4DB3-8DC6-06540D7AAEEDQ50323850-FA13EAAC-74E2-4837-9B50-812FC92067C3Q52653722-38D1AFAD-556C-4EA6-AAF7-F019A01A5E46Q52664558-B86B07B1-5ADC-4796-AA64-304F0DD86481Q55002406-42CC3FC7-0F59-4C03-A704-092F9BE588D0Q55240717-3C876DC0-AE9D-448C-9C20-5802521DBDA1Q57072954-932A1869-2225-4DC7-B122-4354B3F8581D
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Role and mechanism of action of sclerostin in bone.
@en
type
label
Role and mechanism of action of sclerostin in bone.
@en
prefLabel
Role and mechanism of action of sclerostin in bone.
@en
P2860
P1433
P1476
Role and mechanism of action of sclerostin in bone.
@en
P2093
Amy Y Sato
Jesus Delgado-Calle
P2860
P356
10.1016/J.BONE.2016.10.007
P577
2016-10-12T00:00:00Z